MAP1LC3A

mutation — cross-omics
Cross-omicsMUTATION → IMMUNEPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, MAP1LC3A mutation is significantly associated with the immune_cell of many other genes, with 4 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible MAP1LC3A-associated genes across cancer lineages are Endothelial cells, lymphatic Endothelial cells, and mv Endothelial cells. Each is linked with MAP1LC3A in more than 1 cancer types. Because this analysis shows association rather than direction, both MAP1LC3A-to-partner and partner-to-MAP1LC3A results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, Endothelial cells grouped by MAP1LC3A-low versus MAP1LC3A-high in UCEC.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (MAP1LC3A→partner) and Y-score (partner→MAP1LC3A) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
UCECEndothelial cells →-0.053-2.957.016.03711
UCEClymphatic Endothelial cells →-0.030-2.946.031.03711
UCECmv Endothelial cells →-0.034-2.989.014.03711
UCECNKT →-0.132-3.000.032.03711
Each partner links to its Q-omics profile. Showing the 4 strongest of 4 associations by consensus.

Endothelial cells by MAP1LC3A expression — UCEC

Box plot of Endothelial cells in MAP1LC3A-low vs MAP1LC3A-high samples in UCEC.

Explore this box plot interactively →

Exploration